Hjem › Burkitts lymfom › Colorado › Aurora
Kliniske studier for Burkitts lymfom i Aurora, CO
10 studier for Burkitts lymfom søker deltakere på steder i og rundt Aurora (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Children's Hospital Colorado, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
- Children's Hospital Colorado, Aurora
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- Children's Hospital Colorado, Aurora
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
RekruttererFase 1/2
- Children's Hospital Colorado, Aurora
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Children's Hospital Colorado, Aurora
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Children's Hospital Colorado, Aurora
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
RekruttererFase 1
- Children's Hospital Colorado, Aurora
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
RekruttererFase 1/2
- University of Colorado - Aurora Cancer Center, Aurora
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
RekruttererFase 2
- Children's Hospital Colorado, Aurora
Burkitts lymfom-studier i andre byer
- Houston, TX21 studier
- Milwaukee, WI16 studier
- Philadelphia, PA16 studier
- New York City, NY14 studier
- Chicago, IL14 studier
- Cincinnati, OH12 studier
- Atlanta, GA12 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Boston, MA10 studier
- Los Angeles, CA10 studier
- Kansas City, MO10 studier
Andre studier i Aurora
- Kreft (alle typer)35 studier
- Kolorektal kreft32 studier
- Ikke-småcellet lungekreft30 studier
- Brystkreft27 studier
- Metastatisk kreft25 studier
- Eggstokkreft25 studier
- Type 1-diabetes23 studier
- Fedme21 studier
- Lungekreft19 studier
- Prostatakreft19 studier
- Hjertesvikt18 studier
- Melanom18 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.